News

France 3 is relaying Harmonic Pharma’s battle against Covid-19. Learn more here.

Our CSO, Sinan Karaboga, was invited to RTL Grand Soir with Christophe Pacaux. Find the interview here: Interview.

With its drug repurposing platform, Harmonic Pharma has the expertise to identify in a short frame time safe drugs as novel treatment to be investigated for COVID-19 virus.

Harmonic Pharma is offering its services to clinicians willing to test novel treatments resulting from our repurposing program.

Find the details of this partnership in this French release.

Harmonic Pharma is proud to announce a close collaboration with Seqens, a global player of pharmaceutical synthesis in Europe, Asia and America ! Find all the details of this partnership in the polypharmacology field in this release.

Our chief scientific officer, Arnaud Sinan Karaboga, will give a presentation at the 14th Meet & Match event November 27 in Strasbourg. The topic of the day is « Strategies for drug discovery: Simulation – Screening – Repurposing » so be sure to be there !

Harmonica Pharma will also attend the 6th edition of BioFIT, the leading partnering event in Europe for technology transfer the 28th and 29th November.

Harmonic Pharma organizes on Thursday, March 23, 2017, a national day of scientific and technological information on drug pharmacological rediscovery© applied to oncology with key partners in order to provide patients equitable access to innovation. With the support of academic and institutional partners, the initiative mobilizes representatives of health professionals, regulatory authorities, health authorities, charitable, associative and industrial players.

Harmonic Pharma will be part of the 2016 World Cancer Congress in Paris ! You are welcome to visit us at booth #23 of the global village.

“Harmonic Pharma, the French company that brings a new life to therapeutic compounds.”

Harmonic Pharma makes the front page of “L’Est Républicain” journal today!